Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW April 2004

Volume 13
Issue Number 4
April 2004
ISSN 10593802

Organ Transplant and Cancer Risk

The immunosuppressant drug CellCept® significantly lowers the risk of developing post-transplant cancer when used in standard immunosuppressant regimens.
Go to Previous Page
Go to Next Page

Source & Additional Reading

Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT) on April 23, 2004.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW April 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW April 2004